This article's tone or style may not reflect the
encyclopedic tone used on Wikipedia. (October 2014) |
Autistica is a UK based charity engaged in funding and campaigning for research on autism and related conditions. Its research strategy is focused on improving the understanding of mental health, physical health, language and epilepsy in autism. [1]
Founded | 2004 |
---|---|
Founder | Dame Stephanie Shirley |
Headquarters | UK |
Revenue | 3,593,349 pound sterling (2017) |
Number of employees | 15 (2017, 2018) |
Website |
www |
Autistica was founded in 2004 by entrepreneur and philanthropist Dame Stephanie Shirley. [2] [3] They initially operated as a UK partner to the US charity Autism Speaks. [4] The link with the US parent was severed on 1 January 2010. [5] Autistica is registered in and operates throughout England and Wales. [6]
Autistica funds medical research to understand the causes of autism, improve diagnosis, and develop new treatments and interventions. They are the UK's leading autism medical research charity.
Their current scientific priorities are to:
The mission and goals of Autistica are distinct from those of the UK-based National Autistic Society (NAS). While Autistica concentrates its efforts on research into the causes and treatments of autism, with a view to reduce the age of diagnosis, provide effective, evidence-based treatments for people with ASD, particularly co-occurring problems, including epilepsy, attention deficit hyperactivity disorder (ADHD) and severe maladaptive behaviors (SMB) and researching autism and ageing, the NAS focuses on the service needs of autistic individuals. [7]
In 2009, Autistica provided a total of £940,000 to its beneficiaries in autism research. [6]
This article's tone or style may not reflect the
encyclopedic tone used on Wikipedia. (October 2014) |
Autistica is a UK based charity engaged in funding and campaigning for research on autism and related conditions. Its research strategy is focused on improving the understanding of mental health, physical health, language and epilepsy in autism. [1]
Founded | 2004 |
---|---|
Founder | Dame Stephanie Shirley |
Headquarters | UK |
Revenue | 3,593,349 pound sterling (2017) |
Number of employees | 15 (2017, 2018) |
Website |
www |
Autistica was founded in 2004 by entrepreneur and philanthropist Dame Stephanie Shirley. [2] [3] They initially operated as a UK partner to the US charity Autism Speaks. [4] The link with the US parent was severed on 1 January 2010. [5] Autistica is registered in and operates throughout England and Wales. [6]
Autistica funds medical research to understand the causes of autism, improve diagnosis, and develop new treatments and interventions. They are the UK's leading autism medical research charity.
Their current scientific priorities are to:
The mission and goals of Autistica are distinct from those of the UK-based National Autistic Society (NAS). While Autistica concentrates its efforts on research into the causes and treatments of autism, with a view to reduce the age of diagnosis, provide effective, evidence-based treatments for people with ASD, particularly co-occurring problems, including epilepsy, attention deficit hyperactivity disorder (ADHD) and severe maladaptive behaviors (SMB) and researching autism and ageing, the NAS focuses on the service needs of autistic individuals. [7]
In 2009, Autistica provided a total of £940,000 to its beneficiaries in autism research. [6]